Complete Filing Data
Healthcare Triangle, Inc. reported Stockholders Equity of $6.04 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Healthcare Triangle, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income * | -$6.0M | -$8.7M | -$9.6M | -$5.9M | $2.4M |
| Revenues | $11.7M | $33.2M | $45.9M | $35.3M | $31.3M |
| Research And Development Expense | $429.0K | $799.0K | $6.0M | $5.3M | $1.7M |
| Operating Income Loss | -$4.8M | -$7.7M | -$10.4M | -$5.4M | $1.2M |
| General And Administrative Expense | $4.0M | $5.7M | $5.6M | $4.4M | $2.4M |
| Cost Of Revenue | $8.8M | $26.4M | $34.6M | $24.7M | $22.8M |
| Income Tax Expense Benefit | $12.0K | $35.0K | $63.0K | $24.0K | $257.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.0M | -$8.7M | -$9.5M | -$5.9M | $2.6M |
| Operating Expenses | $7.6M | $14.5M | $21.7M | $15.9M | |
| Interest Income Expense Net | -$1.2M | -$968.0K | -$212.0K | -$567.0K | |
| Interest Expense | $212.0K | $567.0K | $78.6K | ||
| Income Taxes Paid | $35.0K | $63.0K | $24.0K | $257.4K | |
| Selling And Marketing Expense | $2.2M | $4.7M | $6.8M | ||
| Net Income Loss Available To Common Stockholders Basic | -$9.6M | -$6.0M | |||
| State And Local Income Tax Expense Benefit Continuing Operations | $24.2K | $76.1K | |||
| Nonoperating Income Expense | -$566.7K | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.9M | -$1.4M | -$1.7M | -$1.2M | -$1.5M | -$1.9M | -$1.9M | -$1.8M | -$3.3M | -$2.3M | -$405.0K | -$2.0M | -$2.0M | $304.0K | -$814.0K | $138.8K |
| Revenues | $3.5M | $3.6M | $3.7M | $2.4M | $3.0M | $4.1M | $7.8M | $8.5M | $9.8M | $12.0M | $11.6M | $11.1M | $8.1M | $10.1M | $8.0M | $7.4M |
| Research And Development Expense | $59.0K | $55.0K | $144.0K | $175.0K | $207.0K | $127.0K | $54.0K | $102.0K | $539.0K | $1.5M | $646.0K | $1.1M | $2.2M | $813.0K | $757.0K | $550.2K |
| Operating Income Loss | -$2.6M | -$1.4M | -$1.4M | -$1.2M | -$1.4M | -$1.7M | -$1.5M | -$1.6M | -$3.2M | -$2.2M | -$1.4M | -$2.0M | -$1.8M | $469.0K | -$716.0K | $191.3K |
| General And Administrative Expense | $2.1M | $1.2M | $1.2M | $1.1M | $904.0K | $1.2M | $1.4M | $1.6M | $1.6M | $1.5M | $1.5M | $1.4M | $753.0K | $1.0M | $1.3M | $582.9K |
| Cost Of Revenue | $2.9M | $3.1M | $3.4M | $1.7M | $2.1M | $3.1M | $6.1M | $6.6M | $8.2M | $8.5M | $8.4M | $8.2M | $5.4M | $6.7M | $5.8M | $5.4M |
| Income Tax Expense Benefit | $2.0K | $1.0K | $5.0K | $4.0K | $5.0K | $19.0K | $37.0K | $1.0K | $21.0K | $1.0K | $1.0K | $3.0K | $51.3K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.9M | -$1.4M | -$1.7M | -$1.2M | -$1.5M | -$1.9M | -$1.9M | -$1.8M | -$3.3M | -$2.3M | -$404.0K | -$2.0M | -$2.0M | $305.0K | -$811.0K | $190.1K |
| Operating Expenses | $3.2M | $1.9M | $1.7M | $1.9M | $2.3M | $2.7M | $3.2M | $3.5M | $4.8M | $5.7M | $4.6M | $4.9M | $4.5M | $2.9M | ||
| Interest Income Expense Net | -$32.0K | -$21.0K | -$413.0K | -$80.0K | -$131.0K | -$149.0K | -$415.0K | -$186.0K | -$62.0K | -$55.0K | -$58.0K | -$16.0K | -$221.0K | |||
| Interest Expense | $62.0K | $58.0K | $16.0K | $220.6K | $164.0K | $95.0K | $1.2K | |||||||||
| Income Taxes Paid | $149.0K | $62.0K | $21.0K | $3.0K | ||||||||||||
| Selling And Marketing Expense | $1.0M | $616.0K | $373.0K | $294.0K | $631.0K | $883.0K | $1.1M | $1.0M | $1.8M | |||||||
| Net Income Loss Available To Common Stockholders Basic | ||||||||||||||||
| State And Local Income Tax Expense Benefit Continuing Operations | $1.0K | $21.0K | -$942.00 | $1.0K | $39.0K | -$15.4K | ||||||||||
| Nonoperating Income Expense | $1.0M | -$16.0K | -$220.6K | -$164.0K | -$95.0K | -$1.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.0M | $16.1M | $4.3M | $2.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.3M | $1.8M | $1.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.2M | -$107.0K | -$429.0K | $367.0K | $427.9K | |
| Cash And Cash Equivalents At Carrying Value | $1.2M | $1.3M | $1.8M | $1.4M | $974.8K | |
| Other Liabilities Current | $1.9M | $2.2M | $869.0K | $789.6K | ||
| Other Assets Current | $824.0K | $816.0K | $362.0K | $228.8K | ||
| Liabilities Current | $8.2M | $6.1M | $6.3M | $6.8M | ||
| Liabilities And Stockholders Equity | $6.9M | $20.8M | $24.6M | $11.1M | ||
| Liabilities | $8.2M | $8.4M | $8.5M | $6.8M | ||
| Assets Current | $5.7M | $7.7M | $11.8M | $8.0M | ||
| Assets | $6.9M | $20.8M | $24.6M | $11.1M | ||
| Accounts Receivable Net Current | $3.6M | $5.6M | $9.7M | $6.4M | ||
| Accounts Payable Current | $2.0M | $1.5M | $1.9M | $4.3M | ||
| Property Plant And Equipment Net | $44.0K | $80.0K | $74.0K | $15.8K | ||
| Retained Earnings Accumulated Deficit | -$27.6M | -$12.6M | -$2.7M | |||
| Finite Lived Intangible Assets Net | $857.0K | $10.6M | $10.5M | $2.6M | ||
| Common Stock Value | $0.00 | $0.00 | $279.00 | |||
| Common Stock Issued For Services | $124.0K | $1.1M | ||||
| Goodwill | $1.3M | $1.3M | ||||
| Asset Acquisition Contingent Consideration Liability | $2.2M | |||||
| Warrant Liability | $55.0K | |||||
| Preferred Stock Voting Shares | 6.0K | 6.0K | ||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | $500.0K | $2.2M | ||||
| Operating Lease Liability | $176.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.7M | $10.2M | $8.6M | -$5.1M | -$1.8M | -$646.0K | -$511.0K | $538.0K | $6.1M | $8.1M | $9.3M | $17.6M | $14.1M | $14.5M | $2.7M | $4.4M | $4.1M | $4.3M | $2.5M | $2.3M | $2.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.6M | $3.2M | $6.8M | $20.0K | $28.0K | $29.0K | $301.0K | $1.2M | $75.0K | $132.0K | $267.0K | $4.1M | $1.4M | $1.6M | $1.1M | $1.6M | $3.0M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $6.8M | -$933.0K | -$1.1M | -$208.0K | $1.6M | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $1.6M | $6.8M | $20.0K | $28.0K | $29.0K | $301.0K | $75.0K | $132.0K | $267.0K | $4.1M | $1.4M | $1.6M | $1.1M | $175.0K | ||||||||
| Other Liabilities Current | $1.1M | $670.0K | $815.0K | $1.4M | $1.4M | $1.2M | $1.0M | $1.4M | $1.3M | $3.0M | $1.0M | $1.4M | $999.0K | $415.4K | ||||||||
| Other Assets Current | $370.0K | $455.0K | $1.1M | $322.0K | $146.0K | $299.0K | $773.0K | $622.0K | $816.0K | $661.0K | $233.0K | $668.0K | $1.4M | $691.4K | ||||||||
| Liabilities Current | $3.9M | $3.2M | $3.2M | $6.6M | $6.1M | $6.2M | $6.0M | $6.9M | $5.8M | $7.3M | $5.1M | $6.1M | $5.5M | $8.7M | ||||||||
| Liabilities And Stockholders Equity | $13.8M | $14.6M | $11.8M | $2.0M | $4.8M | $6.0M | $6.9M | $14.5M | $16.1M | $18.9M | $24.9M | $22.4M | $22.3M | $11.4M | ||||||||
| Liabilities | $5.1M | $4.4M | $3.2M | $7.1M | $6.6M | $6.7M | $7.4M | $8.3M | $8.0M | $9.6M | $7.3M | $8.3M | $7.8M | $8.7M | ||||||||
| Assets Current | $7.9M | $8.9M | $9.8M | $1.9M | $1.8M | $2.3M | $3.2M | $4.9M | $5.4M | $6.4M | $11.1M | $8.6M | $9.7M | $8.5M | ||||||||
| Assets | $13.8M | $14.6M | $11.8M | $2.0M | $4.8M | $6.0M | $6.9M | $14.5M | $16.1M | $18.9M | $24.9M | $22.4M | $22.3M | $11.4M | ||||||||
| Accounts Receivable Net Current | $2.4M | $1.9M | $1.9M | $1.1M | $1.6M | $2.0M | $2.1M | $4.0K | $4.5M | $5.5M | $6.7M | $6.5M | $6.7M | $5.9M | ||||||||
| Accounts Payable Current | $1.3M | $2.1M | $1.6M | $2.5M | $2.3M | $1.9M | $2.0M | $1.2M | $926.0K | $1.3M | $1.5M | $1.3M | $1.6M | $2.6M | ||||||||
| Property Plant And Equipment Net | $5.0K | $3.0K | $12.0K | $17.0K | $24.0K | $33.0K | $49.0K | $57.0K | $67.0K | $76.0K | $81.0K | $90.0K | $51.8K | |||||||||
| Retained Earnings Accumulated Deficit | -$38.5M | -$36.6M | -$35.3M | -$33.6M | -$29.5M | -$28.3M | -$26.8M | -$19.6M | -$17.6M | -$15.8M | -$7.4M | -$5.1M | ||||||||||
| Finite Lived Intangible Assets Net | $3.6M | $8.2M | $8.9M | $9.7M | $11.4M | $11.0M | $9.8M | $2.0M | ||||||||||||||
| Common Stock Value | $11.0K | $14.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $300.00 | ||||||||||||
| Common Stock Issued For Services | $51.0K | $350.0K | -$567.0K | |||||||||||||||||||
| Goodwill | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | ||||||||||||||||
| Asset Acquisition Contingent Consideration Liability | $1.5M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | |||||||||||||||
| Warrant Liability | $190.0K | $795.0K | $55.0K | $55.0K | $55.0K | $55.0K | $55.0K | |||||||||||||||
| Preferred Stock Voting Shares | 6.0K | 6.0K | 6.0K | |||||||||||||||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | $1.2M | $1.2M | $500.0K | $500.0K | $500.0K | $500.0K | ||||||||||||||||
| Operating Lease Liability | $41.0K | $86.0K | $132.0K | $176.0K | $176.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Share-Based Compensation * | $87.0K | $166.0K | $257.0K | $52.0K | |
| Net Cash Provided By Used In Operating Activities | -$1.1M | -$2.2M | -$2.6M | -$7.1M | -$734.7K |
| Net Cash Provided By Used In Financing Activities | -$133.0K | $2.1M | $5.5M | $15.1M | $1.6M |
| Increase Decrease In Accounts Receivable | -$2.3M | -$2.3M | -$4.1M | $3.3M | $2.2M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $593.0K | $484.0K | -$392.0K | -$2.5M | -$750.4K |
| Increase Decrease In Other Current Assets | -$502.0K | $8.0K | $454.0K | $133.0K | $82.3K |
| Depreciation Depletion And Amortization | $889.0K | $1.6M | $3.4M | $1.4M | $803.2K |
| Increase Decrease In Other Current Liabilities | -$525.0K | -$520.0K | $1.3M | $80.0K | -$308.6K |
| Increase Decrease In Due From Related Parties | $193.0K | -$771.0K | $259.0K | $371.0K | $524.0K |
| Net Cash Provided By Used In Investing Activities | -$12.0K | -$3.3M | -$7.6M | -$477.5K | |
| Payments For Proceeds From Productive Assets | $40.0K | $79.0K | |||
| Proceeds From Repayments Of Short Term Debt | -$1.1M | $1.6M | $203.0K | ||
| Proceeds From Short Term Debt | $203.0K | ||||
| Proceeds From Stock Options Exercised | $0.00 | $29.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share-Based Compensation * | $36.0K | $26.0K | $142.0K | $15.0K | $14.0K |
| Net Cash Provided By Used In Operating Activities | -$5.6M | -$50.0K | -$1.6M | $351.0K | -$2.1M |
| Net Cash Provided By Used In Financing Activities | $12.4M | -$883.0K | $533.0K | -$539.0K | $3.7M |
| Increase Decrease In Accounts Receivable | $797.0K | -$1.1M | -$80.0K | -$2.9M | -$8.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$820.0K | $60.0K | -$174.0K | -$295.0K | -$1.1M |
| Increase Decrease In Other Current Assets | $785.0K | -$486.0K | -$155.0K | $1.0M | $834.0K |
| Depreciation Depletion And Amortization | $12.0K | $536.0K | $874.0K | $711.0K | $211.0K |
| Increase Decrease In Other Current Liabilities | -$744.0K | $823.0K | $130.0K | -$73.0K | |
| Increase Decrease In Due From Related Parties | -$271.0K | $276.0K | $451.0K | $81.0K | |
| Net Cash Provided By Used In Investing Activities | -$4.0K | -$20.0K | |||
| Payments For Proceeds From Productive Assets | $2.0K | $20.0K | |||
| Proceeds From Repayments Of Short Term Debt | $186.0K | -$883.0K | $533.0K | ||
| Proceeds From Short Term Debt | $533.0K | -$500.0K | |||
| Proceeds From Stock Options Exercised | $10.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 5.3M | 4.2M | 3.7M | 29.4M | 27.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 5.3M | 4.2M | 3.7M | 29.4M | 27.9M |
| Earnings Per Share Diluted | $-1.13 | $-2.08 | $-2.63 | $-0.20 | $0.08 |
| Earnings Per Share Basic | $-1.13 | $-2.08 | $-2.63 | $-0.20 | $0.08 |
| Common Stock Shares Outstanding | 4.3M | 4.2M | 35.3M | 27.9M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 205.1K | 4.3M | 4.2M | 35.3M | |
| Weighted Average Common Shares Outstanding Basic And Diluted | 36.7M | 29.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 4.4M | 2.3M | 9.8M | 22.8K | 21.4K | 4.5M | 4.3M | 4.3M | 4.2M | 36.0M | 35.5M | 35.5M | 28.8M | 29.6M | 29.3M | 27.9M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 4.4M | 2.3M | 9.8M | 22.8K | 21.4K | 4.5M | 4.3M | 4.3M | 4.2M | 36.0M | 35.5M | 35.5M | 28.8M | 29.6M | 29.3M | 27.9M | ||
| Earnings Per Share Diluted | $-0.42 | $-0.58 | $-0.17 | $-54.78 | $-70.72 | $-0.42 | $-0.45 | $-0.42 | $-0.79 | $-0.01 | $-0.06 | $-0.07 | $0.01 | $-0.03 | $0.01 | |||
| Earnings Per Share Basic | $-0.42 | $-0.58 | $-0.17 | $-54.78 | $-70.72 | $-0.42 | $-0.45 | $-0.42 | $-0.79 | $-0.01 | $-0.06 | $-0.07 | $0.01 | $-0.03 | $0.01 | |||
| Common Stock Shares Outstanding | 4.4M | 5.8M | 16.0M | 22.8K | 5.7M | 5.6M | 4.7M | 4.3M | 4.3M | 41.9M | 39.5M | 35.5M | 35.5M | 30.0M | ||||
| Common Stock Shares Authorized | 2.00B | 2.00B | 100.0M | 2.00B | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Common Stock Shares Issued | 4.4M | 5.8M | 16.0M | 22.8K | 5.7M | 5.6M | 4.7M | 39.5M | 35.5M | 30.0M | 27.9M | |||||||
| Weighted Average Common Shares Outstanding Basic And Diluted | 4.2M | 4.2M | 41.9M | 3.6M | 3.5M | 35.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Depreciation And Amortization | $7.2M | $3.4M | $1.4M | $803.2K | |
| Stock Issued During Period Value Issued For Services | $956.0K | $500.0K | $125.0K | $1.0M | |
| Additional Paid In Capital | $26.2M | $25.0M | $18.8M | $1.0M | |
| Marketing And Advertising Expense | $6.8M | $4.8M | $2.4M | ||
| Short Term Borrowings | $3.8M | $2.4M | $2.2M | ||
| Other Income | $7.0K | $12.0K | $1.1M | $1.5M | |
| Adjustments To Additional Paid In Capital Other | $87.0K | $166.0K | |||
| Net Income Per Common Sharebasic And Diluted | -$0.26 | -$0.20 | |||
| Issue Of Options Isonso | $257.0K | $52.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $17.0K | $257.0K | |||
| Stock Issued During Period Value Other | $2.3M | $700.0K | |||
| Stock Issued During Period Value New Issues | $22.0K | $108.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $63.0K | $343.0K | $534.0K | $536.0K | $712.0K | $802.0K | $874.0K | $909.0K | $844.0K | $711.0K | $211.0K | $211.0K | $211.0K | $200.9K | |||
| Stock Issued During Period Value Issued For Services | $95.0K | $0.00 | $0.00 | $51.0K | $350.0K | $236.0K | $32.0K | $567.0K | |||||||||
| Additional Paid In Capital | $36.8M | $39.4M | $36.4M | $21.0M | $27.7M | $27.6M | $26.3M | $25.7M | $25.7M | $25.1M | $25.0M | $19.2M | $19.2M | $1.9M | |||
| Marketing And Advertising Expense | $1.1M | $1.0M | $1.8M | $1.8M | $1.7M | $1.7M | $1.3M | $805.0K | $668.0K | $476.7K | |||||||
| Short Term Borrowings | $1.5M | $415.0K | $775.0K | $2.7M | $1.1M | $1.7M | $1.8M | $3.5M | $3.5M | $2.9M | $2.5M | $3.2M | |||||
| Other Income | $731.0K | $13.0K | $111.0K | $12.0K | $1.1M | ||||||||||||
| Adjustments To Additional Paid In Capital Other | $416.0K | $36.0K | $77.0K | $25.0K | $26.0K | $20.0K | $35.0K | ||||||||||
| Net Income Per Common Sharebasic And Diluted | -$0.46 | -$0.42 | -$0.08 | -$0.64 | -$0.11 | -$0.06 | -$0.07 | ||||||||||
| Issue Of Options Isonso | $20.0K | $35.0K | $142.0K | $15.0K | $19.1K | ||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $26.0K | $142.0K | $12.0K | $14.0K | |||||||||||||
| Stock Issued During Period Value Other | $956.0K | $787.0K | |||||||||||||||
| Stock Issued During Period Value New Issues | $88.0K | $956.0K | $787.0K | $499.0K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.